Concepedia

Karen L. Murkitt

KL

Statistics

Publications

4

Citations

164

H-Index

4

Active since

1993

Affiliations

Molecular Discovery (United Kingdom)(Current)

New Frontier

Karen L. Murkitt is an author at Molecular Discovery (United Kingdom) specializing in neuropharmacology, medicine, and pharmacology.

Publications per year

1993–2000

4

Publications

4

Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM<sub>1</sub>, hM<sub>2</sub>, hM<sub>3</sub>, hM<sub>4</sub> and hM<sub>5</sub> using microphysiometry

Martyn Wood, Karen L. Murkitt, Michael Ho et al. · British Journal of Pharmacology · 1999 · 64 citations · Full text

, , +14

SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia

Christopher D. Benham, Tom H. Brown, David G. Cooper et al. · Neuropharmacology · 1993 · 51 citations

, , +15

The human GABA<sub>B1b</sub> and GABA<sub>B2</sub> heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen

Martyn Wood, Karen L. Murkitt, Simon Q.J. Rice et al. · British Journal of Pharmacology · 2000 · 30 citations · Full text

, , +17

The Effects of SB 206284A, a Novel Neuronal Calcium-Channel Antagonist, in Models of Cerebral Ischemia

Nigel I. Wood, Frank C. Barone, Christopher D. Benham et al. · Journal of Cerebral Blood Flow & Metabolism · 1997 · 19 citations · Full text

, , +17

1–4 of 4